tldrdaily.news logo
Tag

Diabetes Treatment

All articles tagged with #diabetes treatment

health6 months ago

Ozempic-like Drugs Show Promise for Type 1 Diabetes Treatment

A clinical trial suggests that Ozempic-like drugs, specifically semaglutide, may be effective in treating type 1 diabetes by improving blood sugar control and promoting weight loss, potentially offering a new treatment option alongside insulin. The study involved 72 obese type 1 diabetics, with results showing better blood sugar management and weight loss in those treated with semaglutide, though more research is needed for regulatory approval.

via Live Science|
#diabetes-treatment#glp-1-agonists#health
business1 year ago

Eli Lilly Invests $5.3B to Expand Indiana Plant for Weight-Loss Drugs

Eli Lilly is investing an additional $5.3 billion in its Indiana manufacturing plant to increase the supply of its popular weight loss drug Zepbound and diabetes treatment Mounjaro, bringing the total investment at the site to $9 billion. The plant, expected to start operations by the end of 2026, will help address the high demand and shortages of these drugs. This marks Eli Lilly's largest manufacturing investment in its history.

via CNBC|
#business#diabetes-treatment#eli-lilly
health1 year ago

"Study Reveals Shocking Discrepancy in Ozempic Drug Production Costs"

A study suggests that the popular weight loss jab Ozempic, which can cost up to $1,300, could be manufactured for as little as $5, raising concerns about the immense profit margin. The high demand for the drug, originally intended to treat type 2 diabetes, has led to a shortage and the emergence of potentially dangerous counterfeit medications. The study's authors hope to spark a conversation about fair pricing for medications, as the drugmaker, Novo Nordisk, faces scrutiny over the hefty price tag of Ozempic.

via New York Post |
#diabetes-treatment#health#medication-costs
healthcare1 year ago

"EU Drug Regulator's Review of Lilly's Mounjaro Multi-Dose Pen"

The European Union's healthcare regulator will review Eli Lilly's Mounjaro drug, used for treating type 2 diabetes and obesity, when prefilled in a multi-dose injection pen. The U.S. drugmaker has initially made starter doses available in Germany and Poland packaged in vials, but the "Kwikpen" multi-dose injection device for Mounjaro is now being considered as a new route of administration by an expert panel of the European Medicines Agency. Lilly has indicated that European approval of the pen injector could come by the middle of the year.

via Reuters|
#diabetes-treatment#eli-lilly#eu-drug-regulator
health2 years ago

"Unveiling the Evolution of Weight Loss Medications in Modern Medicine"

Ozempic and other GLP-1 medications are not only proving beneficial for reducing cardiovascular risk and treating diabetes, but also for significant weight loss, with patients losing on average 10 to 20 percent of their body weight in the first year. These drugs are considered life-changing for many overweight or obese individuals and are even seen as a miracle by Wall Street analysts.

via CBS News|
#cardiovascular-risk-reduction#diabetes-treatment#glp-1-medications
health2 years ago

Game-Changing Diabetes Treatment: Long-Lasting Shots Transforming Care

Stanford engineers have developed a groundbreaking hydrogel drug delivery system that allows GLP-1 drugs, used in the treatment of Type 2 diabetes and weight control, to be administered just three times a year instead of daily or weekly injections. The hydrogel slowly releases the drugs over a four-month period, improving patient compliance and long-term health outcomes. The system has shown promising results in laboratory rats and could potentially be applied to other drugs and conditions. Human clinical trials are expected within the next two years.

via SciTechDaily|
#diabetes-treatment#drug-delivery-system#glp-1-drugs
health2 years ago

Mounjaro: The Diabetes Drug That Sheds 60 Pounds for Dieters

A new study has found that the diabetes drug Mounjaro, also known as tirzepatide, helped people with obesity or who are overweight lose an average of 60 pounds when combined with intensive diet and exercise. The drug, made by Eli Lilly & Co., has the potential to be one of the most powerful medical treatments for obesity. Participants in the study who received tirzepatide lost an additional 44 pounds on average, while those who received dummy shots regained some weight. The drug targets hormones that regulate appetite and the feeling of fullness. Side effects such as nausea and diarrhea were reported, but were mostly mild to moderate. Eli Lilly is seeking FDA approval to sell the drug for obesity treatment under a different brand name.

via Yahoo Finance|
#diabetes-treatment#health#mounjaro
business2 years ago

Sigilon Therapeutics Rockets After Acquisition by Eli Lilly

Eli Lilly has announced its acquisition of Sigilon Therapeutics, its partner in diabetes treatment, causing Sigilon's biotech stock to surge by 438.2%. The deal values Sigilon stock at $14.92 per share, with a contingent value right worth up to an additional $111.64 per share in cash tied to clinical and regulatory milestones. The total value of the deal amounts to $309.6 million. The collaboration between Lilly and Sigilon aims to develop innovative islet cell therapy solutions for type 1 diabetes, and Sigilon is also working on treatments for lysosomal and liver diseases.

via Investor's Business Daily|
#biotech-stock#business#cell-therapy